Cresco Labs Inc. (CRLBF) shareholders
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 6, 2026Score 4/30
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 503M shares
Institutional holders
7
1 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Charles Ian Bachtell | 273,752,009 | 20.20% | 13G (passive) | Feb 9, 2024 |
| Thomas J. Manning | 269,739,574 | 20.00% | 13D (active) | Feb 9, 2024 |
| Robert M. Sampson | 267,427,390 | 19.90% | 13D (active) | Feb 9, 2024 |
| Dominic Sergi | 200,291,564 | – | 13G (passive) | Dec 31, 2023 |
| Eminence Capital, LP Joint filing with Ricky C. Sandler (6.30%) | 17,753,792 | 6.30% | 13G (passive) | Dec 31, 2022 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CRLBF | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Albert D Mason Inc | 88,035 | 0.02% | $73.07K | – | 0.04% |
| Ancora Advisors, LLC | 48,028 | 0.01% | $39.61K | −12,141 | 0.00% |
| Hantz Financial Services, Inc. | 9,509 | 0.00% | $8.00K | +489 | 0.00% |
| Strategic Investment Solutions, Inc. /IL | 1,408 | 0.00% | $1.17K | – | 0.00% |
| Thompson Investment Management, Inc. | 725 | 0.00% | $602 | – | 0.00% |
| Massmutual Trust Co Fsb/Adv | 200 | 0.00% | $166 | – | 0.00% |
| Sterling Capital Management LLC | 132 | 0.00% | $110 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 7 | 0M | 0.0% | 1 / 1 | 1 / 4 | 0M | 0M |
| Q1 2026 | 10 | 0M | 0.1% | 2 / 2 | 1 / 2 | 0M | 0M |
| Q4 2025 | 10 | 0M | 0.1% | 2 / 0 | 3 / 2 | 0M | 0M |
| Q3 2025 | 10 | 0M | 0.1% | 0 / 1 | 1 / 1 | 0M | 0M |
| Q2 2025 | 11 | 0M | 0.1% | 1 / 2 | 1 / 2 | 0M | 0M |
| Q1 2025 | 12 | 0M | 0.1% | 2 / 0 | 2 / 1 | 0M | 0M |
| Q4 2024 | 11 | 0M | 0.1% | 3 / 0 | 3 / 1 | 0M | 0M |
| Q3 2024 | 9 | 0M | 0.1% | 1 / 0 | 2 / 1 | 0M | 0M |
| Q2 2024 | 9 | 0M | 0.1% | 2 / 2 | 1 / 1 | 0M | 0M |
| Q1 2024 | 8 | 0M | 0.1% | 1 / 1 | 1 / 1 | 0M | 0M |
| Q4 2023 | 10 | 0M | 0.1% | 2 / 0 | 2 / 4 | 0M | 0M |
| Q3 2023 | 12 | 0M | 0.1% | 1 / 1 | 2 / 4 | 0M | 0M |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
1M shares short
Days to cover
1.4
At 1M shares a day
Change since last report
-21.9%
From 1M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cresco Labs's stock actually held short. Settlement fails (shares not delivered on time) peaked at 262,122 shares on Oct 9, 2026 over the last 90 days.
See a number that looks wrong?